174
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Associations of miRNA-146a and miRNA-223 with Rheumatoid Arthritis and Their Predictive Values

ORCID Icon, , &
Pages 3211-3218 | Received 20 Apr 2023, Accepted 19 Jul 2023, Published online: 31 Jul 2023

References

  • Almutairi K, Nossent J, Preen D, et al. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41(5):863–877. doi:10.1007/s00296-020-04731-0
  • Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11):2857. doi:10.3390/cells10112857
  • Umapathy S, Thulasi R, Gupta N, et al. Thermography and colour Doppler ultrasound: a potential complementary diagnostic tool in evaluation of rheumatoid arthritis in the knee region. Biomed Tech. 2020;65(3):289–299. doi:10.1515/bmt-2019-0051
  • Fujimura K, Haraguchi A, Sakurai R, et al. Have the radiographic characteristics of total knee arthroplasty recipients in rheumatoid arthritis changed after the induction of biologic disease modifying antirheumatic drugs? Mod Rheumatol. 2022;32(6):1047–1053. doi:10.1093/mr/roab114
  • Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10–18. doi:10.1038/s41590-020-00816-x
  • Chen J, Zeng S, Xue Q, et al. Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis. Proc Natl Acad Sci USA. 2022;119(43):e2213373119. doi:10.1073/pnas.2213373119
  • Ptb H, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy. Int J Mol Sci. 2022;23(13):7167. doi:10.3390/ijms23137167
  • Kmiołek T, Paradowska-Gorycka A. miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis. Cells. 2022;11(3):452. doi:10.3390/cells11030452
  • Tavasolian F, Hosseini AZ, Soudi S, et al. miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther. 2020;20(4):297–312. doi:10.2174/1566523220666200916120708
  • Condrat CE, Thompson DC, Barbu MG, et al. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020;9(2):276. doi:10.3390/cells9020276
  • Ul Islam Z, Baneen U, Khaliq T, et al. Association analysis of miRNA-146a and miRNA-499 polymorphisms with rheumatoid arthritis: a case-control and trio-family study. Clin Exp Med. 2022. doi:10.1007/s10238-022-00916-y
  • Yang B, Zhang JL, Shi YY, et al. Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Mol Biol Rep. 2011;38(8):4913–4919. doi:10.1007/s11033-010-0633-x
  • Zhou X, Zhu J, Zhang H, et al. Is the microRNA-146a (rs2910164) polymorphism associated with rheumatoid arthritis? Association of microRNA-146a (rs2910164) polymorphism and rheumatoid arthritis could depend on gender. Joint Bone Spine. 2015;82(3):166–171. doi:10.1016/j.jbspin.2014.12.009
  • Bogunia-Kubik K, Wysoczańska B, Piątek D, et al. Significance of polymorphism and expression of miR-146a and NFkB1 genetic variants in patients with rheumatoid arthritis. Arch Immunol Ther Exp. 2016;64(Suppl 1):131–136. doi:10.1007/s00005-016-0443-5
  • Ahmadi K, Soleimani A, Soleimani Motlagh S, et al. Polymorphisms of pre-miR-499 rs3746444 T/C and pre-miR-146a rs2910164 C/G in the autoimmune diseases of rheumatoid arthritis and systemic lupus erythematosus in the West of Iran. Iran J Public Health. 2020;49(4):782–790.
  • Shaker OG, El Boghdady NA, El Sayed AE. Association of MiRNA-146a, MiRNA-499, IRAK1 and PADI4 polymorphisms with rheumatoid arthritis in Egyptian population. Cell Physiol Biochem. 2018;46(6):2239–2249. doi:10.1159/000489592
  • Ayeldeen G, Nassar Y, Ahmed H, et al. Possible use of miRNAs-146a and −499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis. Mol Cell Biochem. 2018;449(1–2):145–156. doi:10.1007/s11010-018-3351-7
  • Sebastiani GD, Fulci V, Niccolini S, et al. Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients. Clin Exp Rheumatol. 2011;29(6):1058–1059.
  • Dunaeva M, Blom J, Thurlings R, et al. Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis. Clin Exp Immunol. 2018;193(3):376–385. doi:10.1111/cei.13156
  • Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: altered expression and diagnostic potential. Autoimmun Rev. 2015;14(11):1029–1037. doi:10.1016/j.autrev.2015.07.005
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
  • Qu Y, Wu J, Deng JX, et al. MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway. Oncotarget. 2016;7(45):74217–74226. doi:10.18632/oncotarget.12487
  • Kabekkodu SP, Shukla V, Varghese VK, et al. Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc. 2018;93(4):1955–1986. doi:10.1111/brv.12428
  • Huang PY, Wu JG, Gu J, et al. Bioinformatics analysis of miRNA and mRNA expression profiles to reveal the key miRNAs and genes in osteoarthritis. J Orthop Surg Res. 2021;16(1):63. doi:10.1186/s13018-021-02201-2
  • Fu L, Jin L, Yan L, et al. Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility. Hum Immunol. 2016;77(1):1–6. doi:10.1016/j.humimm.2014.09.002
  • Mo ML, Jiang JM, Long XP, et al. miR-144-3p aggravated cartilage injury in rheumatoid arthritis by regulating BMP2/PI3K/Akt axis. Mod Rheumatol. 2022;32(6):1064–1076. doi:10.1093/mr/roab105
  • Quero L, Tiaden AN, Hanser E, et al. miR-221-3p drives the shift of M2-macrophages to a pro-inflammatory function by suppressing JAK3/STAT3 activation. Front Immunol. 2020;10:3087. doi:10.3389/fimmu.2019.03087
  • Cuppen BV, Rossato M, Fritsch-Stork RD, et al; All SRU investigators. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis? Arthritis Res Ther. 2016;18(1):189. doi:10.1186/s13075-016-1085-z
  • El-Bakry RM, Fadda SM, Mohamed RA, et al. Circulating miR-146a −5p in Egyptian patients with rheumatoid arthritis. Egypt J Immunol. 2022;29(1):29–38. doi:10.55133/eji.290104
  • Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142(6):914–929. doi:10.1016/j.cell.2010.08.012
  • Jing X, Gong Z, Li F, et al. Effect of miRNA-146a-mediated TLR4 signal pathway on the pain of lumbar disc herniation. Cell Mol Biol. 2022;68(1):26–34. doi:10.14715/cmb/2022.68.1.5
  • Nakasa T, Shibuya H, Nagata Y, et al. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011;63(6):1582–1590. doi:10.1002/art.30321
  • Duroux-Richard I, Presumey J, Courties G, et al. MicroRNAs as new player in rheumatoid arthritis. Joint Bone Spine. 2011;78(1):17–22. doi:10.1016/j.jbspin.2010.06.003
  • Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103(33):12481–12486. doi:10.1073/pnas.0605298103
  • Zilahi E, Tarr T, Papp G, et al. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren’s syndrome. Immunol Lett. 2012;141(2):165–168. doi:10.1016/j.imlet.2011.09.006
  • Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83–86. doi:10.1126/science.1091903
  • Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem. 2009;284(7):4667–4678. doi:10.1074/jbc.M805777200
  • Li YT, Chen SY, Wang CR, et al. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum. 2012;64(10):3240–3245. doi:10.1002/art.34550